Benefits and Risks of Cannabidiol Therapeutic Approach in Different Treatment Contexts

Abstract

The therapeutic approach grounded in the use of Cannabidiol has emerged as a promising transformation in contemporary medicine by distinguishing its analgesic and non-psychoactive properties from the actions of Tetrahydrocannabinol, offering alternatives for chronic conditions refractory to conventional approaches. Conducting this research is justified by the urgent need to synthesize available scientific evidence to guide clinical practice and address knowledge gaps regarding the safety, efficacy, and socioeconomic viability of this treatment in the national context. Therefore, the main objective of this study is to analyze the pros and cons of Cannabidiol treatment across various healthcare fields. Additionally, the research seeks to evaluate how the substance acts in different treatment contexts, without overlooking precautions regarding drug interactions with other medications. It aims to discuss the financial, legal, and bureaucratic issues that still hinder patient access to continuous treatment in Brazil. This is an academic study based on a literature review and bibliographical analysis of the biological effects, clinical applications, and regulatory aspects of the substance. The clinical application of Cannabidiol demonstrates significant benefits in managing chronic pain, controlling seizures in severe epilepsies, reducing generalized anxiety, attenuating disruptive behaviors in autism, and achieving neuropsychiatric stabilization in elderly patients with Alzheimer's. However, therapy requires continuous monitoring due to the risk of mild to moderate adverse events, potential liver toxicity at high doses, and drug interactions via hepatic enzyme inhibition. Furthermore, bureaucratic hurdles, high costs, and regulatory limitations in Brazil continue to impede broad access to treatment. The balance between benefits and risks of Cannabidiol presents a highly promising and favorable horizon for modern clinical practice, provided it is supported by precise diagnoses, individualized dosage titration, periodic laboratory monitoring, and the overcoming of socioeconomic and legal barriers to ensure continuous access.